(Q37532571)

20 August 2017

1 reference

title

Pharmacogenetics in heart failure: promises and challenges (English)

1 reference

20 August 2017

0 references

2

Pim van der Harst

0 references

Dirk J van Veldhuisen

series ordinal

3

object named as

Dirk J van Veldhuisen

1 reference

20 August 2017

Rudolf A de Boer

1

1 reference

20 August 2017

Pim van der Harst

series ordinal

2

1 reference

20 August 2017

Maarten P van den Berg

series ordinal

4

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 August 2009

1 reference

Expert Opinion on Pharmacotherapy

20 August 2017

1 reference

20 August 2017

10

1 reference

20 August 2017

11

1 reference

20 August 2017

1713-1725

1 reference

Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies.

20 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Pharmacogenomics: the promise of personalized medicine for CNS disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

A pharmacogenomics primer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Pharmacogenetics of the human beta-adrenergic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Pharmacology and physiology of human adrenergic receptor polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial. COMPANION Steering Committee and COMPANION Clinical Investiga

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Role of beta adrenergic receptor polymorphisms in heart failure: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Pharmacogenetics of beta-blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Beta-1 and beta-2 adrenoceptor polymorphisms: functional importance, impact on cardiovascular diseases and drug responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Beta-adrenoceptor blocker treatment and the cardiac beta-adrenoceptor-G-protein(s)-adenylyl cyclase system in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Emerging role of pharmacogenomics in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

The impact of beta-adrenoreceptor gene polymorphisms on survival in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Association between beta-1 and beta-2 adrenergic receptor gene polymorphisms and the response to beta-blockade in patients with stable congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a MERIT-HF sub-study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Real-time optical recording of beta1-adrenergic receptor activation reveals supersensitivity of the Arg389 variant to carvedilol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

The Arg389Gly beta1-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Genetic variation associated with ischemic heart failure: a HuGE review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

The publication process itself was the major cause of publication bias in genetic epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Effects of AGTR1 A1166C gene polymorphism in patients with heart failure treated with candesartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

An aldosterone synthase gene variant is associated with improvement in left ventricular ejection fraction in dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure: results from the A-HeFT Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Usefulness of the aldosterone synthase gene polymorphism C-344-T to predict cardiac remodeling in African-Americans versus non-African-Americans with chronic systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Pharmacogenetic effect of an endothelin-1 haplotype on response to bucindolol therapy in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

The VEGF +405 CC promoter polymorphism is associated with an impaired prognosis in patients with chronic heart failure: a MERIT-HF substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Vascular endothelial growth factor: the link between cardiovascular risk factors and microalbuminuria?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Clinical and genetic issues in familial dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Late gadolinium enhanced cardiovascular magnetic resonance in Becker muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Genetics in heart failure: where are we headed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Genomewide association analysis of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Mapping the genetic architecture of gene expression in human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

From Darwin's finches to canaries in the coal mine--mining the genome for new biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

SLCO1B1 variants and statin-induced myopathy--a genomewide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

HLA-B*5701 screening for hypersensitivity to abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

The largest prospective warfarin-treated cohort supports genetic forecasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

The underreporting of results and possible mechanisms of 'negative' drug trials in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Redefining quality--implications of recent clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Pharmacogenetics in drug discovery and development: a translational perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Telomere Length of Circulating Leukocytes Is Decreased in Patients With Chronic Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Universal risk factors for multifactorial diseases: LifeLines: a three-generation population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Global variation in copy number in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Drug-induced epigenetic changes produce drug tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Severe Myocardial Fibrosis Caused by a Deletion of the 5’ End of the Lamin A/C Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Beta-adrenergic receptor blockade and the angiotensin-converting enzyme deletion polymorphism in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

Identification of a genetic risk factor for idiopathic dilated cardiomyopathy. Involvement of a polymorphism in the endothelin receptor type A gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903025171

10.1517/14656560903025171

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference